Toxicity of inorganic nanomaterials in biomedical imaging

Biotechnology Advances

Volumn 32, Issue 4, 2014, Pages 727-743

  Li, Jinxia ^a   Chang, Xueling ^a   Chen, Xiaoxia ^c   Gu, Zhanjun ^a   Zhao, Feng ^a   Chai, Zhifang ^a,b   Zhao, Yuliang ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Gold nanoparticles; Inorganic materials; Iron nanoparticles; Medical imaging; Nanomedicine; Nanotoxicity; QDs; Upconversion nanoparticles

Indexed keywords

INDICATORS (CHEMICAL); INORGANIC CHEMICALS; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; NANOSTRUCTURED MATERIALS; SYNTHESIS (CHEMICAL);

GOLD NANOPARTICLES; INORGANIC MATERIALS; IRON NANOPARTICLES; NANOTOXICITY; QDS; UPCONVERSION NANOPARTICLES;

TOXICITY;

BIOTECHNOLOGY; CHEMICAL COMPOSITION; DISSOLUTION; GOLD; IMAGING METHOD; IRON; NANOTECHNOLOGY; TOXICITY;

CADMIUM; CONTRAST MEDIUM; GOLD; INORGANIC COMPOUND; IRON; METAL NANOPARTICLE; QUANTUM DOT; REACTIVE OXYGEN METABOLITE;

ANIMAL; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG DESIGN; FEMALE; HUMAN; MOUSE; NANOTECHNOLOGY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PROCEDURES; SURFACE PROPERTY;

ANIMALS; CADMIUM; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DRUG DESIGN; FEMALE; GOLD; HUMANS; INORGANIC CHEMICALS; IRON; METAL NANOPARTICLES; MICE; NANOTECHNOLOGY; OXIDATION-REDUCTION; OXIDATIVE STRESS; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY; QUANTUM DOTS; REACTIVE OXYGEN SPECIES; SURFACE PROPERTIES;

EID: 84901989065     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.12.009     Document Type: Review

References (149)

1. Abdelhalim M.A. Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure. Lipids Health Dis 2011, 10:205-214.
2. Abdelhalim M.A., Jarrar B.M. Renal tissue alterations were size-dependent with smaller ones induced more effects and related with time exposure of gold nanoparticles. Lipids Health Dis 2011, 10:163-169.
3. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61:428-437.
4. Alkilany A.M., Lohse S.E., Murphy C.J. The gold standard: gold nanoparticle libraries to understand the nano-bio interface. Acc Chem Res 2013, 46:650-661.
5. Alkilany A.M., Murphy C.J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?. J Nanopart Res 2010, 12:2313-2333.
6. Alkilany A.M., Nagaria P.K., Hexel C.R., Shaw T.J., Murphy C.J., Wyatt M.D. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 2009, 5:701-708.
7. Almeida J.P., Chen A.L., Foster A., Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine 2011, 6:815-835.
8. Almutairi A., Rossin R., Shokeen M., Hagooly A., Ananth A., Capoccia B., et al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci U S A 2009, 106:685-690.
9. Anzai Y., Piccoli C.W., Outwater E.K., Stanford W., Bluemke D.A., Nurenberg P., et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003, 228:777-788.
10. Apopa P., Qian Y., Shao R., Guo N., Schwegler-Berry D., Pacurari M., et al. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 2009, 6:1. 10.1186/1743-8977-6-1.
11. Arbab A.S., Wilson L.B., Ashari P., Jordan E.K., Lewis B.K., Frank J.A. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 2005, 18:383-389.
12. Auffan M., Decome L., Rose J., Orsiere T., De Meo M., Briois V., et al. In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: a physicochemical and cyto-genotoxical study. Environ Sci Technol 2006, 40:4367-4373.
13. Auffan M., Achouak W., Rose J., Roncato M-A, Chanéac C., Waite D.T., et al. Relation between the redox state of iron-based nanoparticles and their cytotoxicity toward Escherichia coli. Environ Sci Technol 2008, 42:6730-6735.
14. Balasubramanian S.K., Jittiwat J., Manikandan J., Ong C.N., Yu L.E., Ong W.Y. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 2010, 31:2034-2042.
15. Bharali D.J., Mousa S.A. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther 2010, 128:324-335.
16. 3+-containing (hematite) particles for their toxicological properties in human lung cells in vitro. Toxicol Sci 2012, 126:173-182.
17. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38:1759-1782.
18. Bourrinet P., Bengele H.H., Bonnemain B., Dencausse A., Idee J.M., Jacobs P.M., et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 2006, 41:313-324.
19. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008, 60:1615-1626.
20. Cengelli F., Maysinger D., Tschudi-Monnet F., Montet X., Corot C., Petri-Fink A., et al. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 2006, 318:108-116.
21. Chang E., Thekkek N., Yu W.W., Colvin V.L., Drezek R. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2006, 2:1412-1417.
22. 22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 2005, 5:2050-2057.
23. Chen J., Guo C.R., Wang M., Huang L., Wang L.P., Mi C.C., et al. Controllable synthesis of NaYF4: Yb, Er upconversion nanophosphors and their application to in vivo imaging of Caenorhabditis elegans. J Mater Chem 2011, 21:2632-2649.
24. Chen J., Zhao J.X. Upconversion nanomaterials: synthesis, mechanism, and applications in sensing. Sensors 2012, 12:2414-2435.
25. Chen Y.C., Hsiao J.K., Liu H.M., Lai I.Y., Yao M., Hsu S.C., et al. The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Toxicol Appl Pharmacol 2010, 245:272-279.
26. Chen Z., Chen H., Meng H., Xing G.M., Gao X.Y., Sun B.Y., et al. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol 2008, 230:364-371.
27. Chiang C.W., Wang A., Mou C.Y. CO oxidation catalyzed by gold nanoparticles confined in mesoporous aluminosilicate Al-SBA-15: pretreatment methods. Catal Today 2006, 117:220-227.
28. Cho E.C., Glaus C., Chen J., Welch M.J., Xia Y. Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med 2010, 16:561-573.
29. Choi A.O., Brown S.E., Szyf M., Maysinger D. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J Mol Med 2008, 86:291-302.
30. Choi H.S., Frangioni J.V. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging 2010, 9:291-310.
31. Chu M., Wu Q., Yang H., Yuan R., Hou S., Yang Y., et al. Transfer of quantum dots from pregnant mice to pups across the placental barrier. Small 2010, 6:670-678.
32. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
33. Das P., Samantaray S., Rout G. Studies on cadmium toxicity in plants: a review. Environ Pollut 1997, 98:29-36.
34. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
35. Derfus A.M., Chan W.C., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
36. Duconge F., Pons T., Pestourie C., Herin L., Theze B., Gombert K., et al. Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjug Chem 2008, 19:1921-1926.
37. Ehrenberg M.S., Friedman A.E., Finkelstein J.N., Oberdörster G., McGrath J.L. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 2009, 30:603-610.
38. Facey K., Bradbury I., Laking G., Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Asses 2007, 11. [iii-iv, xi-267].
39. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 2010, 62:362-374.
40. Feng J.H., Liu H.L., Bhakoo K.K., Lu L.H., Chen Z. A metabonomic analysis of organ specific response to USPIO administration. Biomaterials 2011, 32:6558-6569.
41. Fierro-Gonzalez J.C., Gates B.C. Evidence of active species in CO oxidation catalyzed by highly dispersed supported gold. Catal Today 2007, 122:201-210.
42. Fitzpatrick J.A., Andreko S.K., Ernst L.A., Waggoner A.S., Ballou B., Bruchez M.P. Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett 2009, 9:2736-2741.
43. Fröhlich E., Kueznik T., Samberger C., Roblegg E., Wrighton C., Pieber T.R. Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. Toxicol Appl Pharmacol 2010, 242:326-332.
44. Gao X.H., Cui Y.Y., Levenson R.M., Chung L.W., Nie S.M. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
45. Gao X.H., Dave S.R. Quantum dots for cancer molecular imaging. Adv Exp Med Biol 2007, 620:57-73.
46. Gao X.H., Yang L.L., Petros J.A., Marshall F.F., Simons J.W., Nie S.M. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005, 16:63-72.
47. Ge C.C., Lao F., Li W., Li Y.F., Chen C.Y., Mao X.Y., et al. Quantitative analysis of metal impurities in carbon nanotubes: efficacy of different pretreatment protocols for ICP-MS spectroscopy. Anal Chem 2008, 80:9426-9434.
48. Ge C.C., Li Y., Yin J.J., Liu Y., Wang L.M., Zhao Y.L., et al. The contributions of metal impurities and tube structure to the toxicity of carbon nanotube materials 2012, 4:e32. NPG Asia Materials. 10.1038/am.2012.60.
49. Ge C.C., Du J.F., Zhao L.N., Wang L.M., Liu Y., Li D.H., et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A 2011, 108:16968-16973.
50. Geys J., Nemmar A., Verbeken E., Smolders E., Ratoi M., Hoylaerts M.F., et al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 2008, 116:1607-1613.
51. Guo S.T., Huang Y.Y., Jiang Q., Sun Y., Deng L.D., Liang Z.C., et al. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010, 4:5505-5511.
52. Hanini A., Schmitt A., Kacem K., Chau F., Ammar S., Gavard J. Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomedicine 2011, 6:787-794.
53. Hohnholt M.C., Geppert M., Luther E.M., Petters C., Bulcke F., Dringen R. Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem Res 2012, 38:227-239.
54. Hong S.C., Lee J.H., Lee J., Kim H.Y., Park J.Y., Cho J., et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomedicine 2011, 6:3219-3231.
55. Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y.F., Ohta T., et al. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 2004, 4:2163-2169.
56. Isomaa B., Ekman K. Embryotoxic and teratogenic effects of CTAB, a cationic surfactant, in the mouse. Food Cosmet Toxicol 1975, 13:331-334.
57. Jayakumar M.K., Idris N.M., Zhang Y. Remote activation of biomolecules in deep tissues using near-infrared-to-UV upconversion nanotransducers. Proc Natl Acad Sci U S A 2012, 109:8483-8488.
58. 3+upconversion nanoparticles for charge-dependent cellular imaging. ACS Nano 2011, 5:7838-7847.
59. Joo S.H., Feitz A.J., Sedlak D.L., Waite T.D. Quantification of the oxidizing capacity of nanoparticulate zero-valent iron. Environ Sci Technol 2005, 39:1263-1268.
60. 22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U S A 2012, 109:15431-15436.
61. Kato S., Itoh K., Yaoi T., Tozawa T., Yoshikawa Y., Yasui H., et al. Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain. Nanotechnology 2010, 21:335103-335110.
62. Kim D.K., Mikhaylova M., Zhang Y., Muhammed M. Protective coating of superparamagnetic iron oxide nanoparticles. Chem Mater 2003, 15:1617-1627.
63. Kuo T.R., Lee C.F., Lin S.J., Dong C.Y., Chen C.C., Tan H.Y. Studies of intracorneal distribution and cytotoxicity of quantum dots: risk assessment of eye exposure. Chem Res Toxicol 2011, 24:253-261.
64. Lee D.E., Koo H., Sun I.C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41:2656-2672.
65. Li J.J., Hartono D., Ong C.N., Bay B.H., Yung L.-Y.L. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003.
66. Li J.J., Zou L., Hartono D., Ong C.N., Bay B.H., Lanry Yung L.Y. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv Mater 2008, 20:138-142.
67. Li Y.Y., Zhou Y.L., Wang H.Y., Perrett S., Zhao Y.L., Tang Z.Y., et al. Chirality of glutathione surface coating affects the cytotoxicity of quantum dots. Angew Chem Int Ed Engl 2011, 50:5860-5864.
68. Liang X.J., Meng H., Wang Y.Z., He H.Y., Meng J., Lu J., et al. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A 2010, 107:7449-7454.
69. Lin H., Datar R.H. Medical applications of nanotechnology. Natl Med J India 2006, 19:27-32.
70. Liu W., Zhang S.P., Wang L.X., Qu C., Zhang C.W., Hong L., et al. CdSe quantum dot (QD)-induced morphological and functional impairments to liver in mice. PloS One 2011, 6:e24406. 10.1371/journal.pone.0024406.
71. Lovrić J., Bazzi H.S., Cuie Y., Fortin G.R., Winnik F.M., Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005, 83:377-385.
72. Lovrić J., Cho S.J., Winnik F.M., Maysinger D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 2005, 12:1227-1234.
73. Lu A.H., Salabas E.L., Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007, 46:1222-1244.
74. Lu H.Y., Shiao N.H., Chan W.H. CdSe quantum dots induce apoptosis via activation of JNK and PAK2 in a human osteoblast cell line. J Med Biol Eng 2006, 26:89-96.
75. Ma X.W., Wu Y.Y., Jin S.B., Tian Y., Zhang X.N., Zhao Y.L., et al. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 2011, 5:8629-8639.
76. Mironava T., Hadjiargyrou M., Simon M., Jurukovski V., Rafailovich M.H. Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time. Nanotoxicology 2010, 4:120-137.
77. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7:779-786.
78. Nabiev I., Mitchell S., Davies A., Williams Y., Kelleher D., Moore R., et al. Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett 2007, 7:3452-3461.
79. Nath R., Prasad R., Palinal V., Chopra R. Molecular basis of cadmium toxicity. Prog Food Nutr Sci 1984, 8:109-163.
80. Nel A., Zhao Y., Madler L. Environmental health and safety considerations for nanotechnology. Acc Chem Res 2013, 46:605-606.
81. Neuwelt E.A., Hamilton B.E., Varallyay C.G., Rooney W.R., Edelman R.D., Jacobs P.M., et al. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?. Kidney Int 2009, 75:465-474.
82. Noori A., Parivar K., Modaresi M., Messripour M., Yousefi M.H., Amiri G.R. Effect of magnetic iron oxide nanoparticles on pregnancy and testicular development of mice. Afr J Biotechnol 2011, 10:1221-1227.
83. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., et al. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
84. Phelps M.E. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000, 41:661-681.
85. Pisanic T.R., Blackwell J.D., Shubayev V.I., Finones R.R., Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28:2572-2581.
86. Pissuwan D., Valenzuela S., Cortie M.B. Prospects for gold nanorod particles in diagnostic and therapeutic applications. Biotechnol Genet Eng Rev 2008, 25:93-112.
87. Ponka P. Cellular iron metabolism. Kidney Int 1999, 55:S2-S11.
88. Pouliquen D., Perroud H., Calza F., Jallet P., Le Jeune J. Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI. Magn Reson Med 1992, 24:75-84.
89. Qiao R.R., Yang C.H., Gao M.Y. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. J Mater Chem 2009, 19:6274-6293.
90. Qiu Y., Liu Y., Wang L.M., Xu L.G., Bai R., Ji Y.L., et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31:7606-7619.
91. Qu Y., Li W., Zhou Y.L., Liu X.F., Zhang L., Wang L.M., et al. Full assessment of fate and physiological behavior of quantum dots utilizing Caenorhabditis elegans as a model organism. Nano Lett 2011, 11:3174-3183.
92. 4 core/shell upconversion nanoparticles for bioimaging and drug delivery. RSC Adv 2012, 2:7037-7041.
93. Ritschel W.A., Kearns G.L. Handbook of basic pharmacokinetics-including clinical applications 2004, American Pharmacists Association, Washington, DC.
94. Rivet C.J., Yuan Y., Borca-Tasciuc D.A., Gilbert R.J. Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 2012, 25:153-161.
95. 4: Yb, Er Upconversion Nanoparticles. 4th Kuala Lumpur International Conference on. Biomed Eng 2008, 21:82-85.
96. Rzigalinski B.A., Strobl J.S. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 2009, 238:280-288.
97. 2 nanoparticles in mice. J Nanosci Nanotechnol 2012, 12:8287-8292.
98. Samir T.M., Mansour M.M., Kazmierczak S.C., Azzazy H.M. Quantum dots: heralding a brighter future for clinical diagnostics. Nanomedicine 2012, 7:1755-1769.
99. Schaeublin N.M., Braydich-Stolle L.K., Schrand A.M., Miller J.M., Hutchison J., Schlager J.J., et al. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 2011, 3:410-420.
100. Sereemaspun A., Hongpiticharoen P., Rojanathanes R., Maneewattanapinyo P., Ekgasit S., Warisnoicharoen W. Inhibition of human cytochrome P450 enzymes by metallic nanoparticles: a preliminary to nanogenomics. Int J Pharmacol 2008, 4:492-495.
101. Siddiqi N.J., Abdelhalim M.A., El-Ansary A.K., Alhomida A.S., Ong W.Y. Identification of potential biomarkers of gold nanoparticle toxicity in rat brains. J Neuroinflammation 2012, 9:123-130.
102. Singh N., Jenkins G.J., Nelson B.C., Marquis B.J., Maffeis T.G., Brown A.P., et al. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 2012, 33:163-170.
103. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A 2006, 103:3357-3362.
104. Sun C.J., Yang H., Yuan Y., Tian X., Wang L.M., Guo Y., et al. Controlling assembly of paired gold clusters within apoferritin nanoreactor for in vivo kidney targeting and biomedical imaging. J Am Chem Soc 2011, 133:8617-8624.
105. Szalay B., Tatrai E., Nyiro G., Vezer T., Dura G. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J Appl Toxicol 2012, 32:446-453.
106. Tang J., Huang J., Man S.-Q. Preparation of gold nanoparticles by surfactant-promoted reductive reaction without extra reducing agent. Spectrochim Acta A Mol Biomol Spectrosc 2013, 103:345-355.
107. Taylor A., Wilson K.M., Murray P., Fernig D.G., Levy R. Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet?. Chem Soc Rev 2012, 41:2707-2717.
108. Tedesco S., Doyle H., Redmond G., Sheehan D. Gold nanoparticles and oxidative stress in Mytilus edulis. Mar Environ Res 2008, 66:131-133.
109. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 2011, 5:7155-7167.
110. Uboldi C., Bonacchi D., Lorenzi G., Hermanns M.I., Pohl C., Baldi G., et al. Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part Fibre Toxicol 2009, 6:18-30.
111. Villiers C.L., Freitas H., Couderc R., Villiers M.B., Marche P.N. Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J Nanopart Res 2010, 12:55-60.
112. Voinov M.A., Sosa Pagan J.O., Morrison E., Smirnova T.I., Smirnov A.I. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J Am Chem Soc 2011, 133:35-41.
113. Voura E.B., Jaiswal J.K., Mattoussi H., Simon S.M. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 2004, 10:993-998.
114. 3 particles in brain: micro-distribution, chemical states, and histopathological observation. Biol Trace Elem Res 2007, 118:233-243.
115. Wang B., Feng W.Y., Zhu M.T., Wang Y., Wang M., Gu Y.Q., et al. Neurotoxicity of low-dose repeatedly intranasal instillation of nano- and submicron-sized ferric oxide particles in mice. J Nanopart Res 2009, 11:41-53.
116. Wang B., He X., Zhang Z.Y., Zhao Y.L., Feng W.Y. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc Chem Res 2013, 46:761-769.
117. 3 particles. Chem Anal (Warsaw) 2008, 53:927-942.
118. Wang C., Tao H.Q., Cheng L., Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
119. Wang L.M., Liu Y., Li W., Jiang X.M., Ji Y.L., Wu X.C., et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 2011, 11:772-780.
120. 4: Yb, Er upconversion nanoparticles. ACS Nano 2009, 3:1580-1586.
121. Wang Y., Wang B., Zhu M.T., Li M., Wang H.J., Wang M., et al. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 2011, 205:26-37.
122. Wang Y.L., Cui Y.Y., Zhao Y.L., Liu R., Sun Z.P., Li W., et al. Bifunctional peptides: precisely biomineralize Au clusters and specifically stain cell nuclei. Chem Commun 2012, 48:871-873.
123. Welch M.J., Hawker C.J., Wooley K.L. The Advantages of nanoparticles for PET. J Nucl Med 2009, 50:1743-1746.
124. Xia A., Gao Y., Zhou J., Li C., Yang T., Wu D., et al. Core-shell NaYF4:Yb3+, Tm3+@Fe2O3 nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. Biomaterials 2011, 32:7200-7208.
125. Xiong L., Yang T.S., Yang Y., Xu C.J., Li F.Y. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31:7078-7085.
126. Xu L.G., Liu Y., Chen Z.Y., Li W., Liu Y., Wang L.M., et al. Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment. Nano Lett 2012, 12:2003-2012.
127. Yan L., Gu Z.J., Zhao Y.L. Chemical mechanisms of toxicological property of nanomaterials: intracellular ROS generation. Chem Asian J 2013, [2013]. 10.1002/asia.201300542.
128. Yan L., Zheng Y.B., Zhao F., Li S.J., Gao X.F., Xu B.Q., et al. Chemistry and physics of a single atomic layer: strategies and challenges for functionalization of graphene and graphene-based materials. Chem Soc Rev 2012, 41:97-114.
129. Yan M., Zhang Y., Xu K.D., Fu T., Qin H.Y., Zheng X.X. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology 2011, 282:94-103.
130. Yang H., Sun C.J., Fan Z.L., Tian X., Yan L., Du L.B., et al. Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy. Sci Rep 2012, 2:847-852.
131. Yang M., Cheng K., Qi S.B., Liu H.G., Jiang Y.X., Jiang H., et al. Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials 2013, 34:2796-2806.
132. + doping and their application for bioimaging. Chem Eur J 2012, 18:9239-9245.
133. Yu M.K., Jeong Y.Y., Park J., Park S., Kim J.W., Min J.J., et al. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed Engl 2008, 47:5362-5365.
134. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008, 83:761-769.
135. Zhang Q., Hitchins V.M., Schrand A.M., Hussain S.M., Goering P.L. Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of proinflammatory mediators. Nanotoxicology 2011, 5:284-295.
136. Zhang T., Qian L., Tang M., Xue Y.Y., Kong L., Zhang S.S., et al. Evaluation on cytotoxicity and genotoxicity of the l-glutamic acid coated iron oxide nanoparticles. J Nanosci Nanotechnol 2012, 12:2866-2873.
137. Zhang W.X. Nanoscale iron particles for environmental remediation: an overview. J Nanopart Res 2003, 5:323-332.
138. Zhang X.D., Wu D., Shen X., Liu P.X., Fan F.Y., Fan S.J. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 2012, 33:4628-4638.
139. Zhang Y., Li B., Chen C.Y., Gao Z.H. Hepatic distribution of iron, copper, zinc and cadmium-containing proteins in normal and iron overload mice. Biometals 2009, 22:251-259.
140. Zhao F., Zhao Y., Liu Y., Chang X.L., Chen C.Y., Zhao Y.L. Cellular uptake, intracellular trafficking and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.
141. Zhao Y.L., Li H.L., Gao Z.H., Xu H.B. Effects of dietary baicalin supplementation on iron overload-induced mouse liver oxidative injury. Eur J Pharmacol 2005, 509:195-200.
142. Zhou J., Liu Z., Li F.Y. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2011, 41:1323-1349.
143. Zhou J.C., Yang Z.L., Dong W., Tang R.J., Sun L.D., Yan C.H. Bioimaging and toxicity assessments of near-infrared upconversion luminescent NaYF4:Yb, Tm nanocrystals. Biomaterials 2011, 32:9059-9067.
144. Zhu M., Nie G., Meng H., Xia T., Nel A., Zhao Y. Physicochemical properties determine nanomaterial cellular uptake, transport and fate. Acc Chem Res 2012, 46:622-631.
145. Zhu M.T., Feng W.Y., Wang B., Wang T.C., Gu Y.Q., Wang M., et al. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology 2008, 247:102-111.
146. Zhu M.T., Feng W.Y., Wang Y., Wang B., Wang M., Ouyang H., et al. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci 2009, 107:342-351.
147. Zhu M.T., Wang B., Wang Y., Yuan L., Wang H.J., Wang M., et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett 2011, 203:162-171.
148. Zhu M.T., Wang Y., Feng W.Y., Wang B., Wang M., Ouyang H., et al. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. J Nanosci Nanotechnol 2010, 10:8584-8590.
149. Zhu X.S., Tian S.Y., Cai Z.H. Toxicity assessment of iron oxide nanoparticles in zebrafish (Danio rerio) early life stages. PloS One 2012, 7:e46286. 10.1371/journal.pone.0046286.